We are pleased to announce that the paper, “Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic... read more →
HepQuant is proud to sponsor Team Rocky Mountain (TRM), a local team participating in the 2026 Transplant Games, taking place June 18–23 in Denver. Representing 145 transplant recipients, living... read more →
Dr. Greg T. Everson presented at the annual PSC Forum 9 in Washington, DC, sharing how the oral cholate challenge test can help clinicians more accurately assess disease severity... read more →
Dr. Greg Everson just shared groundbreaking insights at the Liver Forum in Paris! His presentation highlights how HepQuant DuO™ helps estimate clinical risk and track changes over time... read more →
Our amazing lab team is the backbone of our company, powering innovation, precision, and progress every single day. Their dedication to science, quality, and patient impact makes everything we do... read more →